Double trouble: Are lupus and malignancy associated?

Lupus

Volumn 10, Issue 6, 2001, Pages 388-391

  Ramsey Goldman, R ^a   Clarke, A E ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY;

APOPTOSIS; AUTOIMMUNE DISEASE; CANCER INCIDENCE; CANCER RISK; CONNECTIVE TISSUE DISEASE; DISEASE ASSOCIATION; EDITORIAL; HEMATOLOGIC DISEASE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LUNG CARCINOMA; LUPUS ERYTHEMATOSUS; MALIGNANT NEOPLASTIC DISEASE; PRIORITY JOURNAL; RHEUMATIC DISEASE; RISK FACTOR; SJOEGREN SYNDROME;

LUPUS ERYTHEMATOSUS, SYSTEMIC; NEOPLASMS;

EID: 0034979559     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1191/096120301678646100     Document Type: Editorial

References (45)

1. Malignant neoplasms in autoimmune rheumatic diseases. Examination of the risk of developing a malignancy among five different rheumatic diseases in one institution
2. Autoimmune rheumatic diseases and cancer: Evidence or causality?
3. The environment and disease: Association or causation?
4. Risk of cancer in patients with dermatomyositis or polymyositis. A population based study
5. Frequency of specific cancer types in dermatomyositis and polymyositis: A population-based study
6. Nodal and extranodal lymphoproliferative disorders in Sjogren's syndrome: A clinical and immunopathological study
7. Cancer and systemic sclerosis, an epidemiologic study
8. Incidence of cancer among men with the Felty's syndrome
9. Systemic lupus erythematosus and the risk of malignancy
10. Increased risk of cancer in patients with systemic lupus erythematosus
11. Non-Hodgkin's lymphoma and other cancers among a cohort of patients with systemic lupus erythematosus
12. Systemic lupus erythematosus and lymphoma: Association with an antiphospholipid syndrome
13. Systemic lupus erythematosus and lymphoma
14. Non-Hodgkin's lymphoma in systemic lupus erythematosus. Report of 4 cases with ultrastructural studies in 2
15. Systemic rheumatic diseases and malignant lymphoma
16. Malignancy in systemic lupus erythematosus
17. Burkitt's lymphoma in a patient with systemic lupus erythematosus
18. Chronic lymphocytic leukemia in a patient with systemic lupus erythematosus
19. Incidence studies of systemic lupus erythematosus in Southern Sweden: Increasing age, decreasing frequency of renal manifestations and good prognosis
20. Is there an association of malignancy with SLE? An analysis of 276 patients under longterm review
21. Malignancy in a series of 70 patients with systemic lupus erythematosus
22. Frequency of neoplasia in systemic lupus and rheumatoid arthritis
23. Increased incidence of cervical atypia in women with systemic lupus erythematosus treated with chemotherapy
24. SLE: Predisposition for uterine cervical dysplasia
25. Increased cervical dysplasia in intravenous cyclophosphamide-treated patients with SLE: A preliminary study
26. Increased risk of malignancy in patients with systemic lupus erythematosus
27. Bladder cancer after cyclophosphamide therapy for lupus nephritis
28. Primary intracerebral lymphoma in systemic lupus erythematosus treated with immunosuppressives
29. Acute nonlymphycytic leukemia following short-term intermittent, intravenous cyclophosphamide treatment of lupus nephritis
30. Cancer in connective tissue disease
31. Malignancy in systemic lupus erythematosus: A report of five cases in a series of 96 patients
32. The association of malignancy with SLE: An analysis of 150 patients under long-term review
33. The infrequent association of systemic lupus erythematosus and solid tumors
34. Risk of malignancy in female patients with systemic lupus erythematosus
35. The incidence of cancer in patients with systemic lupus erythematosus
36. Malignancy as complication of immunosuppressive therapy
37. Acute granulocytic leukemia following systemic lupus erythematosus
38. Reticulum cell sarcoma in azathioprine-treated systemic lupus erythematosus
39. Anaplastic myeloma in systemic lupus erythematosus
40. Cyclophosphamide treatment of systemic lupus erythematous: Risk of bladder cancer exceeds benefits
41. Bladder leiomyosarcoma following cyclophosphamide therapy for lupus nephritis
42. The 1982 revised criteria for the classification of SLE
43. Updating the American college of rheumatology revised criteria for the classification of systemic lupus erythematosus
44. Validity of self-reported cancer history: A comparison of health interview data and cancer registry records